Your browser doesn't support javascript.
loading
Functional gait disorders: Demographic and clinical correlations.
Tinazzi, Michele; Pilotto, Andrea; Morgante, Francesca; Marcuzzo, Enrico; Cuoco, Sofia; Ceravolo, Roberto; Mazzucchi, Sonia; Padovani, Alessandro; Romito, Luigi Michele; Eleopra, Roberto; Nicoletti, Alessandra; Dallocchio, Carlo; Arbasino, Carla; Bono, Francesco; Magro, Giuseppe; Demartini, Benedetta; Gambini, Orsola; Modugno, Nicola; Olivola, Enrica; Bonanni, Laura; Zanolin, Elisabetta; Albanese, Alberto; Ferrazzano, Gina; Tessitore, Alessandro; Lopiano, Leonardo; Calandra-Buonaura, Giovanna; Petracca, Martina; Esposito, Marcello; Pisani, Antonio; Manganotti, Paolo; Tesolin, Lucia; Teatini, Francesco; Defazio, Giovanni; Ercoli, Tommaso; Stocchi, Fabrizio; Erro, Roberto; Zappia, Mario; Geroin, Christian.
Afiliação
  • Tinazzi M; Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. Electronic address: michele.tinazzi@univr.it.
  • Pilotto A; Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Italy; FERB Onlus, Ospedale S. Isidoro, Trescore Balneario, Bergamo, Italy.
  • Morgante F; Neurosciences Research Centre, Molecular and Clinical Sciences Neurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom; Department of Experimental and Clinical Medicine, University of Messina, Messina, Italy.
  • Marcuzzo E; Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Cuoco S; Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry -Scuola Medica Salernitana, University of Salerno, Baronissi, SA, Italy.
  • Ceravolo R; Center for NeuroDegenerative Diseases Parkinson and Movement Disorders, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Mazzucchi S; Center for NeuroDegenerative Diseases Parkinson and Movement Disorders, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Padovani A; Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Italy.
  • Romito LM; Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Eleopra R; Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Nicoletti A; Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.
  • Dallocchio C; Department of Medical Area, Neurology Unit, ASST Pavia, Italy.
  • Arbasino C; Department of Medical Area, Neurology Unit, ASST Pavia, Italy.
  • Bono F; Botulinum Toxin Center, Neurology Unit A.O.U. Mater Domini, Catanzaro, Italy.
  • Magro G; Botulinum Toxin Center, Neurology Unit A.O.U. Mater Domini, Catanzaro, Italy.
  • Demartini B; Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.
  • Gambini O; Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.
  • Modugno N; IRCCS Neuromed, Pozzilli, Italy.
  • Olivola E; IRCCS Neuromed, Pozzilli, Italy.
  • Bonanni L; Department of Neuroscience, Imaging and Clinical Sciences, University G. D'Annunzio, Chieti-Pescara, Italy.
  • Zanolin E; Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Albanese A; Department of Neurology, IRCCS Humanitas Research Hospital, Rozzano Milan, Italy.
  • Ferrazzano G; Department of Human Neurosciences, Università La Sapienza, Rome, Italy.
  • Tessitore A; Department of Advanced Medical and Surgery Sciences, University of Campania - Luigi Vanvitelli, Naples, Italy.
  • Lopiano L; Department of Neuroscience - Rita Levi Montalcini, University of Turin, Turin, Italy.
  • Calandra-Buonaura G; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Petracca M; Movement Disorder Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Esposito M; Clinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy.
  • Pisani A; IRCCS Mondino Foundation, Pavia, Italy; Department of Brain and Behavioral Sciences, University of Pavia, Italy.
  • Manganotti P; Clinical Neurology Unit, Department of Medical, Surgical and Health Services, University of Trieste, Trieste, Italy.
  • Tesolin L; Functional Movement Disorders Outpt.Clinic, Clinical Neurology and Stroke Unit Dep., Central Country Hospital, Bolzano, Italy.
  • Teatini F; Functional Movement Disorders Outpt.Clinic, Clinical Neurology and Stroke Unit Dep., Central Country Hospital, Bolzano, Italy.
  • Defazio G; Department of Medical Sciences and Public Health, University of Cagliari, Italy.
  • Ercoli T; Department of Medical Sciences and Public Health, University of Cagliari, Italy.
  • Stocchi F; University and Institute of Research and Medical Care San Raffaele Roma, Rome, Italy.
  • Erro R; Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry -Scuola Medica Salernitana, University of Salerno, Baronissi, SA, Italy.
  • Zappia M; Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.
  • Geroin C; Neurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. Electronic address: christian.geroin@univr.it.
Parkinsonism Relat Disord ; 91: 32-36, 2021 10.
Article em En | MEDLINE | ID: mdl-34479056
ABSTRACT

OBJECTIVE:

We aimed to describe the prevalence and clinical-demographical features of patients with functional gait disorders (FGDs) and to compare them to patients with functional motor disorders (FMDs) without FGDs (No-FGDs).

METHODS:

In this multicenter observational study, we enrolled patients with a clinically definite diagnosis of FMDs in 25 tertiary movement disorders centers in Italy. Each subject with FMDs underwent a comprehensive clinical assessment, including screening for different subtypes of functional gait disorders. Multivariate regression models were implemented in order to estimate the adjusted odds ratio (OR; 95% confidence interval) of having FGDs in relation to sociodemographic and clinical characteristics.

RESULTS:

Out of 410 FMDs, 26.6% (n = 109) of patients exhibited FGDs. The most frequent FGDs were slow gait (n = 43, 39.4%), astasia-abasia (n = 26, 23.8%), and knee buckling (n = 24, 22%). They exhibited single FGDs in 51.4% (n = 56) or complex FGDs (more than one type of FGDs) in 48.6% (n = 53) of cases. On multivariate regression analysis, the presence of FGDs was more likely associated with older age (OR 1.03, 95% CI 1.01-1.04), functional visual symptoms (OR 2.19, 95% CI 1.08-4.45), and the diagnosis of somatic symptoms disorder (OR 2.97, 95% CI 1.08-8.17). FGDs were also more likely to undergo physiotherapy (OR 1.81, 95% CI 1.08-3.03).

CONCLUSIONS:

People with FMDs may present with different and overlapping types of FGDs, which may occur in older age. The association of FGDs with functional visual symptoms and somatic symptoms disorder opens up to new avenues to the understanding of the neural mechanisms of these disorders.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Neurológicos da Marcha / Transtornos Motores Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Neurológicos da Marcha / Transtornos Motores Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article